Skip to content

USFDA accepts Dr Reddy#39;s Biologics License Application for review; stock dips

Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.

Read More

​ Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets. Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish